论文部分内容阅读
目的评价纤溶酶对急性脑梗死的治疗效果。方法将78例急性脑梗死患者随机分为观察组和对照组进行对比,观察组42例,对照组36例。对照组予基础治疗。观察组在对照组基础治疗上加予纤溶酶100 U,静脉注射,1次/d,连用14 d,进行疗效评定。结果观察组比对照组治愈率、显效率皆显著提高,神经功能缺损明显改善。结论纤溶酶治疗急性脑梗死疗效显著。
Objective To evaluate the therapeutic effect of plasmin on acute cerebral infarction. Methods 78 patients with acute cerebral infarction were randomly divided into observation group and control group, 42 cases in observation group and 36 cases in control group. Control group to basic treatment. The observation group was treated with 100 U of plasmin on the basis of the control group, intravenous injection, once a day for 14 days, and the curative effect was evaluated. Results Compared with the control group, the cure rate and markedly effective rate of the observation group were significantly increased, and the neurological deficits were significantly improved. Conclusion Plasminogen treatment of acute cerebral infarction significant effect.